Close Menu
Home » Mayo Tells Supreme Court Congress Should Clarify Patent Eligibility Confusion in Diagnostics

Mayo Tells Supreme Court Congress Should Clarify Patent Eligibility Confusion in Diagnostics

Nov 25, 2019
|
Turna Ray
Premium

This article has been corrected from a previous version to note that Athena Diagnostics filed its writ of certiorari with the Supreme Court, not the Court of Appeals for the Federal Circuit.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Nobel Representation

In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Bill to Address Foreign Influence

Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research. 

Promising, But More Needed

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

Cell Studies Tackle Tissue Clones, Ocean Microbes, Polygenic Trait Prediction

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.

Featured White Papers

By National Decision Support Company, a Change Healthcare company
The New PAMA Math: Laboratory Data Key to Overcoming Medicare Cuts

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.